| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,500 |
1,724 |
$774K |
| 80053 |
Comprehensive metabolic panel |
4,525 |
3,751 |
$654K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,192 |
2,092 |
$488K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,934 |
6,438 |
$389K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,591 |
4,487 |
$260K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,945 |
959 |
$212K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,434 |
1,426 |
$204K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,783 |
574 |
$201K |
| 81001 |
|
2,534 |
2,322 |
$174K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,492 |
1,420 |
$167K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
3,172 |
1,781 |
$157K |
| J3490 |
Unclassified drugs |
1,134 |
699 |
$86K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
373 |
359 |
$82K |
| 81003 |
|
1,316 |
1,237 |
$69K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,407 |
2,062 |
$68K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,126 |
1,754 |
$47K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,417 |
744 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
679 |
592 |
$40K |
| 84703 |
|
2,028 |
1,923 |
$38K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
453 |
429 |
$37K |
| 71046 |
Radiologic examination, chest; 2 views |
858 |
823 |
$35K |
| 87070 |
|
679 |
661 |
$35K |
| 70450 |
Computed tomography, head or brain; without contrast material |
573 |
528 |
$30K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
494 |
383 |
$29K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,160 |
1,839 |
$25K |
| A9150 |
Non-prescription drugs |
389 |
262 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
1,470 |
1,347 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,190 |
5,274 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,794 |
2,265 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,324 |
1,113 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
140 |
132 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,670 |
1,463 |
$4K |
| 85610 |
|
244 |
218 |
$3K |
| 80305 |
|
29 |
29 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,690 |
1,620 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
223 |
189 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
17 |
15 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
151 |
132 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,074 |
1,739 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
397 |
366 |
$1K |
| 84702 |
|
32 |
25 |
$901.03 |
| 76641 |
|
12 |
12 |
$833.55 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,495 |
1,176 |
$805.87 |
| 94664 |
|
67 |
65 |
$557.49 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
861 |
815 |
$539.88 |
| 84484 |
|
845 |
684 |
$229.17 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
619 |
590 |
$157.75 |
| 87807 |
|
173 |
169 |
$147.91 |
| 87081 |
|
42 |
41 |
$124.43 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
161 |
155 |
$81.05 |
| 80076 |
|
15 |
15 |
$63.64 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
884 |
744 |
$46.28 |
| 87040 |
|
86 |
55 |
$41.28 |
| 83690 |
|
1,107 |
991 |
$40.98 |
| 87077 |
|
132 |
123 |
$33.56 |
| 83605 |
|
284 |
261 |
$27.43 |
| 83735 |
|
448 |
373 |
$22.79 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$22.58 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
789 |
708 |
$22.25 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,062 |
738 |
$17.67 |
| 82550 |
|
155 |
139 |
$5.79 |
| 82150 |
|
30 |
29 |
$5.18 |
| 84100 |
|
82 |
67 |
$3.00 |
| 87430 |
|
391 |
384 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
275 |
242 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
128 |
115 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
17 |
12 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
39 |
38 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
18 |
18 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
106 |
91 |
$0.00 |
| 86901 |
|
28 |
26 |
$0.00 |
| 86140 |
|
61 |
52 |
$0.00 |
| 96376 |
|
19 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
23 |
12 |
$0.00 |
| 85730 |
|
27 |
25 |
$0.00 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
13 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
13 |
13 |
$0.00 |